North America Pharmaceutical Fluid Handling Market

The North America pharmaceutical fluid handling market is expected to grow from US$ 4,553.21 million in 2022 to US$ 6,075.94 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

Increasing Drug Production Fuels North America Pharmaceutical Fluid Handling Market Growth

Pharmaceutical fluid handling is an integral part of the pharmaceutical industry to ensure that fluids such as cough syrups, intravenous products, and complex active pharmaceutical ingredients are delivered in a safe and timely manner. To succeed and be reliable, businesses need to utilize the correct handling equipment and instruments. The manufacturing divisions in the biotechnology & pharmaceutical industry require fluid control systems since most processes involve the presence of a liquid such as feed media, buffer solutions, cell extracts, and product fractions. In recent years, research and development efforts have increased along with investments in developing innovative treatments. The US Food & Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) approved 35 medicines for “biologic drugs” in 2019, and ~50 novel drugs were approved in 2021. Further, ~410 novel drugs have been approved in the past decade, registering approximately 40 approvals each year. The Medicine Development for Global Health (MDGH), in collaboration with the World Health Organization (WHO) Special Program for Research and Training and GlaxoSmithKline, initiated the development of new drugs for tropical diseases and Malaria Venture (MMV) in 2018. This initiation is promoting more clinical trials and drug discovery, which is increasing the number of drug approvals, thereby boosting the pharmaceutical fluid handling market. In addition, according to the National Library of Medicine (NLM), in 2021, the number of registered clinical studies with posted results accounted for 52,537, and it is likely to reach 56,100 by 2022. Moreover, there has been an increase in R&D spending in recent years. For instance, according to data published by Congressional Budget Office in April 2021, the spending on drug R&D increased by ~50% from 2015 to 2019. In 2019, the pharmaceutical industry spent US$ 83 billion on R&D, which increased by ten times compared to the past decade. The rise in the number of clinical trials, increase in drug production, and high investments in R&D are a few factors contributing to the growth of the North America pharmaceutical fluid handling market.

North America Pharmaceutical Fluid Handling Market Overview

The North America pharmaceutical fluid handling market is segmented into the US, Canada, and Mexico. The market growth in this region is due to the rising R&D investments, increasing number of product offerings by key companies, and the growing need for cold and cough remedies. The US dominated the North America pharmaceutical fluid handling market in 2022. There has been a surge in research and development activities and heavy investments in developing novel therapeutics that offer valuable medical benefits. The quantity of approved drugs is significantly high; however, the US FDA approves only 12% of drugs participating in clinical trials. This fuels R&D activities in the biopharmaceutical sector that are anticipated to increase in the coming years. The growth in research activities is also due to the rising demand for fluid handling systems, as these instruments are crucial in dispensing liquid samples in exact quantities.

North America Pharmaceutical Fluid Handling Market Revenue and Forecast to 2028 (US$ Million)

North America Pharmaceutical Fluid Handling Strategic Insights

Strategic insights for the North America Pharmaceutical Fluid Handling provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Pharmaceutical Fluid Handling Report Scope

North America Pharmaceutical Fluid Handling Regional Insights

The geographic scope of the North America Pharmaceutical Fluid Handling refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Pharmaceutical Fluid Handling Market Segmentation

The North America pharmaceutical fluid handling market is segmented on the basis of offering, tubing, application, usage, end user, and country.

Based on offering, the North America pharmaceutical fluid handling market is bifurcated into equipment and solutions & services. The equipment segment registered a larger market share in 2022.

Based on tubing, the North America pharmaceutical fluid handling market is segmented into TPE, PVC, and silicon. The silicon segment registered the largest market share in 2022.

Based on application, the North America pharmaceutical fluid handling market is segmented into fluid handling and management, fluid preparation, integration and automation, aseptic processing, buffer management, and others. The fluid handling and management segment registered the largest market share in 2022.

Based on usage, the North America pharmaceutical fluid handling market is categorized into cough syrup, intravenous products, complex active pharmaceutical ingredients (APIs), and others. The cough syrup segment registered the largest market share in 2022.

Based on end user, the North America pharmaceutical fluid handling market is segmented into biotechnology companies, pharmaceutical & medical companies, and others. The biotechnology companies segment registered the largest market share in 2022.

Based on country, the North America pharmaceutical fluid handling market is segmented into US, Canada, and Mexico. The US registered the largest market share in 2022.

CIRCOR International Inc, Danaher Corp, Merck KGaA, Parker Hannifin Corp, RAUMEDIC AG, Rochling SE & Co KG, Spirax Sarco Engineering plc, and Tef Cap Industries Inc are the leading companies operating in the North America pharmaceutical fluid handling market.